TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Xanthohumol, Praziquantel
Phytochemical Name Xanthohumol (PubChem CID: 639665 )
Anticancer drug Name Praziquantel (PubChem CID: 4891 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 652
Pair Name Xanthohumol, Praziquantel
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Induction-->Oxidative Stress
Gene Regulation Down-regulation Expression CD44 hsa960
Down-regulation Phosphorylation MAPK14 hsa1432
Down-regulation Expression TFRC hsa7037
In Vivo Model Six- to eight-week-old male Syrian golden hamsters were randomly divided into four groups as followings: group I, Ov infection and NDMA administration (ON); group II, Ov infection and NDMA administration and PZ treatment (ONP); groups III and IV were similar to group I and II, they received 20 μM XN (171 mg/B.W./day) designated as XON and XONP groups, respectively.
Result XN administered in combination with PZ could efficiently prevent CCA development and hence provide potential chemopreventive benefits in Ov-induced cholangiocarcinogenesis
03. Reference
No. Title Href
1 Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. PeerJ. 2018 Jan 22;6:e4281. doi: 10.7717/peerj.4281. Click
It has been 48618 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP